TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
EDIT

Editas Medicine Inc

Healthcare · Biotechnology

2.60$ -6.2% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

Editas Medicine Inc (EDIT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -165 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow EDIT
Line item 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-2.8 -8.7 -5.4 -50 -9.4 -46 -41 -180 -164 -177 -132 -210 -165
0.0 0.2 0.5 1.2 2.7 3.3 2.8 4.0 5.1 6.3 6.1 5.8 5.3
0.1 0.1 3.5 17 23 27 27 23 43 29 20 21 10
– 1.9 41 28 38 38 24 51 45 29 – – –
1.2 4.1 63 19 71 27 66 -102 -21 8.2 -1.6 3.5 -31
0.2 1.2 1.4 3.5 2.1 4.8 6.2 7.2 8.0 4.1 4.7 8.8 0.6
-0.2 -1.2 -1.4 -5.1 -184 -53 12 -141 -54 114 -3.7 162 139
– – 143 0.8 0.0 0.0 – – – – – – –
– 0.0 0.0 0.0 0.0 0.0 132 224 282 1.3 – – –
– 0.5 -0.5 -0.6 -1.4 -0.9 – – – – – – –
9.0 18 139 97 155 87 132 224 282 1.3 118 56 40
6.0 8.6 133 42 -39 -12 103 -96 64 -62 -18 7.9 14
-2.9 -9.9 -6.8 -53 -11 -50 -47 -187 -172 -181 -137 -219 -166

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?